Miscellaneous Dermatological Conditions

C-Reative Protein Levels and Spontaneous Urticaria: Is There a Link?

December 06, 2017

The researchers found that one-third of patients exhibiting CSU had elevated levels of CRP.

FDA Expands Use of DESCRIBE PFD Patch for Laser Treatment of Tattoos

By December 04, 2017

The Patch, which is placed over tattoos prior to removal with a laser, allows physicians to treat tattoos more efficiently by enabling rapid multiple laser passes in a single treatment session.

Survey Shows Atopic Dermatitis Often Inadequately Controlled

December 01, 2017

The control rate increased with current AD severity and was 53.4% among patients receiving immunosuppressants and 83.4% among patients receiving systemic corticosteroids.

Hidradenitis Suppurativa: Pharmacological and Surgical Txs Reviewed

By November 29, 2017

The authors reported significant disability and comorbidities among patients with HS, including obesity, metabolic syndrome, diabetes, and arthritis.

Sunscreen Ingredient Linked to Dermatological and Environmental Toxicity

November 22, 2017

Increased adverse reactions may be result of closed loop involving ingesting fish, washing ingredient off

Some Prescription-Strength Meds May Be Easily Acquired Over-the-Counter

November 03, 2017

"Dermatologists and primary care physicians should be cognizant of any over-the-counter product that their patients are using," the authors of a JAMA report write.

Rare Disorder Causes Patient to Spontaneously 'Sweat Blood'

By October 24, 2017

During the patient's admission, a bleeding episode occurred which resulted in blood-stained fluid on her face.

Proton Pump Inhibitor Use Linked to Two Distinct Dermatological Reactions

By October 18, 2017

The case involved a 32-year-old male who was prescribed pantoprazole after initially presenting with dyspepsia-like symptoms.

Investigational Hyperhidrosis Therapy Found to Be Safe, Effective

By October 13, 2017

Daily treatment with glycopyrronium tosylate in the Phase 3, open-label ARIDO trial was generally well-tolerated during 44 weeks of treatment.

Has Mass Media Criteria for What Constitutes Beauty Evolved?

October 12, 2017

In 1990, Fitzpatrick skin types I to III represented 88% of the celebrities on the list and Fitzpatrick skin types IV to VI represented 12%; in contrast, in 2017, Fitzpatrick skin types I to III and IV to VI represented 70.4 and 29.6%, respectively

Case: Tattoo Ink-Induced Lymphadenopathy Misdiagnosed as Cancer

October 04, 2017

Case report describes patient with multiple enlarged lymph nodes seen on PET-CT years after tattoo

International Eczema Council Reach Consensus on Corticosteroid Use

September 26, 2017

In specific circumstances, systemic corticosteroids can be used rarely for severe atopic dermatitis, such as lack of other treatment options, as a bridge to other systemic therapies or phototherapy, during acute flares that need immediate relief, in anticipation of a major life event, or in the most severe cases.

Tuberculosis Vaccine May Carry Dermatological Benefits for Newborns

September 25, 2017

There was a significant difference in the effect of neonatal BCG vaccination between children with atopic predisposition and children without atopic predisposition.

Hair Regrowth in Alopecia Patients After Fecal Transplant for Recurrent CDI

By September 22, 2017

These 2 cases suggests that fecal transplants can have a profound immunological response not only limited to intestinal effects, say the authros.

Dupixent Improves Disease Severity, Skin Clearing in Atopic Dermatitis

By September 20, 2017

The data indicated 59% of patients given Dupixent weekly with topical corticosteroids and 63% of patients given Dupixent every 2 weeks with topical corticosteroids achieved EASI-75 vs. 30% of patients given placebo with topical corticosteroids (P<0.0001).

AAP Publish First Guidance on Tattooing, Piercing for Adolescents

By September 18, 2017

These can occur from contamination of the inks or diluents used for tattooing.

Cemiplimab Gains Breakthrough Tx Designation for Advanced Skin Cancer

By September 08, 2017

A Phase 2, single-arm, open-label clinical trial, EMPOWER-CSCC 1, is now enrolling patients with metastatic CSCC and locally advanced and unresectable CSCC.

Economic Evidence Lacking for Vitiligo Treatment

August 17, 2017

Research reveals no evidence to support or refute value for money afforded by vitiligo treatments.

Anti-Aging Tx Interest Similar Across Patient Gender, Age and Income

August 14, 2017

The researchers found that 53% of the general dermatology patient population has used an anti-aging treatment in the past, and 66% reporting interest in future use.

Intradermal Hyaluronic Acid Efficacy Examined for Facial Pores

August 11, 2017

The researchers observed a significant difference in the appearance of enlarged facial pores (P<0.01) before and after treatment. There were no reports of infection, nodules, or pigmentation at the injection sites.

Octagam 10% Gains Orphan Drug Status for Rare Muscle, Skin Disorder

July 17, 2017

Octagam 10% is currently approved to treat chronic immune thrombocytopenic purpura (ITP) in adult patients. It is supplied as 2g, 5g, 10g, or 20g single-use bottles.

High-Dose Vitamin D May Benefit Skin After Sunburn

By July 07, 2017

The study found that subjects who took the highest doses of vitamin D had long-term benefits, including reduced skin inflammation 48 hours after the burn.

Hidradenitis Suppurativa Severity Scoring System Created

June 27, 2017

The number of nodules, abscesses, and draining tunnels were used to calculate the resulting International HS Severity Scoring System (IHS4) score.

Adverse Events Related to Cosmetics, Personal Care Products Underreported

June 27, 2017

Complaints more than doubled between 2015 and 2016, rising from 706 to 1,591 reported adverse events.

Sleep Disorder Treatment Linked to Serious Skin Side Effect

By June 12, 2017

Serious rash, including SJS, is a reported adverse event in the prescribing information for both modafinil and armodafinil.

RA Drug Linked to Severe Skin Reaction in Patient with Adult-Onset Still Disease

June 01, 2017

Diffuse, persistent, pruritic maculopapular rash developed 10 days after tocilizumab treatment

PRP Injections Promising for Female Pattern Hair Loss

May 18, 2017

Significant improvement in hair volume and quality in PRP-injected sites, plus patient satisfaction

Early Treatment Key for Managing Nasal Hemangiomas

May 17, 2017

General consensus supporting early multimodality treatment for infantile hemangiomas of the nose

Adding a Steroid May Not be Necessary in Acute Urticaria Management

By May 03, 2017

Results showed that the placebo group actually had a greater reduction in itch score, with 76% of this group having an itch score of 0 compared to 62% of patients in the prednisone group.

Visuals Work in Discouraging Indoor Tanning

May 02, 2017

A total of 568 undergraduate females were randomized to either 1 of 3 message conditions visually depicting health effects, appearance damage, or immediate risks, or to a text-only control.